699810P
PHAD®-504
Manufacturer: Sigma Aldrich
CAS Number: 1332714-01-8
Synonym(S): Monophosphoryl Lipid A-504
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 699810P-1-MG | In Stock | ₹ 31,803.85 |
| 5 MG | 699810P-5-MG | In Stock | ₹ 1,27,053.03 |
699810P - 1 MG
In Stock
Quantity
1
Base Price: ₹ 31,803.85
GST (18%): ₹ 5,724.693
Total Price: ₹ 37,528.543
Assay
>99% (HPLC)
form
powder
packaging
pkg of 1 × 1 mg (699810P-1mg)pkg of 1 × 5 mg (699810P-5mg)
manufacturer/tradename
Avanti Polar Lipids
application(s)
vaccine development
shipped in
dry ice
storage temp.
−20°C
Related Products
Description
- General description: PHAD®-504 was designed as a synthetic structural analog of detoxified monophosphoryl lipid A (MPLA) derived from E. coli lipopolysaccharide (LPS). It is structurally similar to PHAD®, differing only in the length of a single fatty acid chain. As expected, the activity of PHAD®-504 is quite similar to that of PHAD®, making the two products interchangeable as adjuvants in vaccine or immunotherapy formulations.
- Packaging: 2 mL Amber Glass Crimp Cap Vial (699810P-1mg)
- Other Notes: For R&D use only. Not for drug, household, or other uses.
- Legal Information: PHAD is a registered trademark of Avanti Polar Lipids, Inc.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
No data available
Flash Point(C)
No data available
Compare Similar Items
Show Difference
Assay: >99% (HPLC)
form: powder
packaging: pkg of 1 × 1 mg (699810P-1mg)pkg of 1 × 5 mg (699810P-5mg)
manufacturer/tradename: Avanti Polar Lipids
application(s): vaccine development
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (HPLC)
form:
powder
packaging:
pkg of 1 × 1 mg (699810P-1mg)pkg of 1 × 5 mg (699810P-5mg)
manufacturer/tradename:
Avanti Polar Lipids
application(s):
vaccine development
shipped in:
dry ice
storage temp.:
−20°C
Assay: ≥95% (GC)
form: __
packaging: __
manufacturer/tradename: __
application(s): __
shipped in: __
storage temp.: 2-30°C
Assay:
≥95% (GC)
form:
__
packaging:
__
manufacturer/tradename:
__
application(s):
__
shipped in:
__
storage temp.:
2-30°C
Assay: 97%
form: powder
packaging: __
manufacturer/tradename: __
application(s): __
shipped in: __
storage temp.: __
Assay:
97%
form:
powder
packaging:
__
manufacturer/tradename:
__
application(s):
__
shipped in:
__
storage temp.:
__
Assay: >99% (HPLC)
form: powder
packaging: pkg of 1 × 1 mg (699851P-1mg)pkg of 1 × 5 mg (699851P-5mg)
manufacturer/tradename: Avanti Polar Lipids 699851P
application(s): vaccine development
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (HPLC)
form:
powder
packaging:
pkg of 1 × 1 mg (699851P-1mg)pkg of 1 × 5 mg (699851P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 699851P
application(s):
vaccine development
shipped in:
dry ice
storage temp.:
−20°C